8SIB

Cryo-EM structure of TRPM7 MHR1-3 domain

Summary for 8SIB

• Entry DOI: 10.2210/pdb8sib/pdb
• Related: 8SI2 8SI3 8SI4 8SI5 8SI6 8SI7 8SI8 8SIA
• EMDB information: 40496 40497 40498 40499 40500 40501 40502 40504 40505
• Descriptor: Transient receptor potential cation channel subfamily M member 7 (1 entity in total)
• Functional Keywords: transient receptor potential m family member 7, trp, channel, trpm7, trp channels, membrane protein, magnesium channel
• Biological source: Mus musculus (house mouse)
• Total number of polymer chains: 1
• Total formula weight: 146888.88

Authors

Nadezhdin, K.D.,Neuberger, A.,Sobolevsky, A.I. (deposition date: 2023-04-14, release date: 2023-05-17, Last modification date: 2024-10-30)

Primary citation

Nadezhdin, K.D.,Correia, L.,Narangoda, C.,Patel, D.S.,Neuberger, A.,Gudermann, T.,Kurnikova, M.G.,Chubanov, V.,Sobolevsky, A.I.
Structural mechanisms of TRPM7 activation and inhibition.
Nat Commun, 14:2639-2639, 2023

PubMed Abstract: The transient receptor potential channel TRPM7 is a master regulator of the organismal balance of divalent cations that plays an essential role in embryonic development, immune responses, cell mobility, proliferation, and differentiation. TRPM7 is implicated in neuronal and cardiovascular disorders, tumor progression and has emerged as a new drug target. Here we use cryo-EM, functional analysis, and molecular dynamics simulations to uncover two distinct structural mechanisms of TRPM7 activation by a gain-of-function mutation and by the agonist naltriben, which show different conformational dynamics and domain involvement. We identify a binding site for highly potent and selective inhibitors and show that they act by stabilizing the TRPM7 closed state. The discovered structural mechanisms provide foundations for understanding the molecular basis of TRPM7 channelopathies and drug development.

PubMed: 37156763
DOI: 10.1038/s41467-023-38362-3

Experimental method

ELECTRON MICROSCOPY (2.62 Å)